290 related articles for article (PubMed ID: 25093806)
1. Disordered hepcidin-ferroportin signaling promotes breast cancer growth.
Zhang S; Chen Y; Guo W; Yuan L; Zhang D; Xu Y; Nemeth E; Ganz T; Liu S
Cell Signal; 2014 Nov; 26(11):2539-50. PubMed ID: 25093806
[TBL] [Abstract][Full Text] [Related]
2. An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis.
Guo W; Zhang S; Chen Y; Zhang D; Yuan L; Cong H; Liu S
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):703-15. PubMed ID: 26201356
[TBL] [Abstract][Full Text] [Related]
3. Disordered signaling governing ferroportin transcription favors breast cancer growth.
Chen Y; Zhang S; Wang X; Guo W; Wang L; Zhang D; Yuan L; Zhang Z; Xu Y; Liu S
Cell Signal; 2015 Jan; 27(1):168-76. PubMed ID: 25451081
[TBL] [Abstract][Full Text] [Related]
4. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
[TBL] [Abstract][Full Text] [Related]
5. Ferroportin and iron regulation in breast cancer progression and prognosis.
Pinnix ZK; Miller LD; Wang W; D'Agostino R; Kute T; Willingham MC; Hatcher H; Tesfay L; Sui G; Di X; Torti SV; Torti FM
Sci Transl Med; 2010 Aug; 2(43):43ra56. PubMed ID: 20686179
[TBL] [Abstract][Full Text] [Related]
6. Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes.
Ikeda Y; Tajima S; Izawa-Ishizawa Y; Kihira Y; Ishizawa K; Tomita S; Tsuchiya K; Tamaki T
PLoS One; 2012; 7(7):e40465. PubMed ID: 22792339
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin-ferroportin axis in health and disease.
Ginzburg YZ
Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways regulating hepcidin.
Rishi G; Subramaniam VN
Vitam Horm; 2019; 110():47-70. PubMed ID: 30798816
[TBL] [Abstract][Full Text] [Related]
9. Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.
Blanchette-Farra N; Kita D; Konstorum A; Tesfay L; Lemler D; Hegde P; Claffey KP; Torti FM; Torti SV
Oncogene; 2018 Jul; 37(29):4013-4032. PubMed ID: 29695834
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M
World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936
[TBL] [Abstract][Full Text] [Related]
11. E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin.
Zhou Q; Chen J; Feng J; Wang J
Cell Death Dis; 2018 Sep; 9(10):987. PubMed ID: 30250199
[TBL] [Abstract][Full Text] [Related]
12. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
Lakhal-Littleton S; Wolna M; Chung YJ; Christian HC; Heather LC; Brescia M; Ball V; Diaz R; Santos A; Biggs D; Clarke K; Davies B; Robbins PA
Elife; 2016 Nov; 5():. PubMed ID: 27897970
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
14. Modulation of hepcidin to treat iron deregulation: potential clinical applications.
Blanchette NL; Manz DH; Torti FM; Torti SV
Expert Rev Hematol; 2016; 9(2):169-86. PubMed ID: 26669208
[TBL] [Abstract][Full Text] [Related]
15. Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin.
Latour C; Kautz L; Besson-Fournier C; Island ML; Canonne-Hergaux F; Loréal O; Ganz T; Coppin H; Roth MP
Hepatology; 2014 Feb; 59(2):683-94. PubMed ID: 23907767
[TBL] [Abstract][Full Text] [Related]
16. Hamp1 but not Hamp2 regulates ferroportin in fish with two functionally distinct hepcidin types.
Neves JV; Ramos MF; Moreira AC; Silva T; Gomes MS; Rodrigues PNS
Sci Rep; 2017 Nov; 7(1):14793. PubMed ID: 29093559
[TBL] [Abstract][Full Text] [Related]
17. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6.
Canali S; Wang CY; Zumbrennen-Bullough KB; Bayer A; Babitt JL
Am J Hematol; 2017 Nov; 92(11):1204-1213. PubMed ID: 28815688
[TBL] [Abstract][Full Text] [Related]
19. UBA6 and NDFIP1 regulate the degradation of ferroportin.
Traeger L; Wiegand SB; Sauer AJ; Corman BHP; Peneyra KM; Wunderer F; Fischbach A; Bagchi A; Malhotra R; Zapol WM; Bloch DB
Haematologica; 2022 Feb; 107(2):478-488. PubMed ID: 34320783
[TBL] [Abstract][Full Text] [Related]
20. Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.
Nekhai S; Xu M; Foster A; Kasvosve I; Diaz S; Machado RF; Castro OL; Kato GJ; Taylor JG; Gordeuk VR
Haematologica; 2013 Mar; 98(3):455-63. PubMed ID: 23065513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
